Month: January 2024

The cloud gaming car specific service provides high quality games at 60 FPS and in Full HD for the whole family, directly from the appThe project sees SoraStream white-labeled as XPLAY from Ludium Lab, and enabled through the Twine4Car app store platform from ACCESS provided in XPENG vehicles.The project sees SoraStream white-labeled as XPLAY from Ludium Lab, and enabled through the Twine4Car app store platform from ACCESS provided in XPENG vehicles.BARCELONA, Spain and OBERHAUSEN, Germany and AMSTERDAM, Jan. 04, 2024 (GLOBE NEWSWIRE) — ACCESS, Ludium Lab, and XPENG today announced they have collaborated to make cloud gaming for in-car displays a reality. This project combines ACCESS IVI (in-vehicle infotainment) technology with Ludium Lab’s cloud gaming platform to enable XPENG customers can enjoy state-of-the-art...

LONDON, January 04, 2023 – Avenir LNG Limited (“Avenir”) today announces it has executed two Time Charter Agreements for the Avenir Advantage and the Avenir Accolade. Avenir’s affiliate Future Horizon (L) Pte Ltd (a joint venture between Avenir and MISC) has signed a new two-year time charter agreement with PETCO Trading Labuan Company Ltd (PTLCL), a trading arm of PETRONAS. Avenir will continue to collaborate with PTLCL by providing LNG as a marine fuel to their customers in Malaysia and Southeast Asia. In addition, Avenir has entered into an agreement to time charter the Avenir Accolade for a period of up to two years with NFE Transport Partners LLC, a subsidiary of New Fortress Energy Inc. The Avenir Accolade has been serving New Fortress Energy Inc. under a bareboat contract. This new Time Charter agreement demonstrates Avenir’s commitment...

Press contact:Florence LievreTel.: +33 1 47 54 50 71Email: florence.lievre@capgemini.com While connected products are increasingly being adopted, 65% of consumers would prefer one interface to enable interoperability across devices Paris, January 4, 2023 – Connected devices1 have become an integral part of life for consumers according to the Capgemini Research Institute’s latest report “Connected products: Enhancing consumers’ lives with technology”. The research found that over a third of consumers plan to buy more connected devices in the next year, with health and home security devices set to drive the most sales. While consumers have an insatiable appetite for connected products, they expect vendors to take greater responsibility for sustainability issues such as e-waste2 and ensure stronger data protection. The survey found that 67%...

Aspocomp Group Plc, Inside Information, January 4, 2024, at 9:20 a.m. Aspocomp Group Plc starts change negotiations on possible temporary layoffs and redundancies in Finland. Today, on January 4, 2024, Aspocomp has issued a negotiation proposal in accordance with the Act on Cooperation to start change negotiations for production-related and financial reasons. The company’s entire personnel in Finland, approximately 150 people, are covered by the negotiations. According to a preliminary estimate, change negotiations could result to temporary layoffs and, in addition, to the termination of a maximum 5 positions. Change negotiations will be initiated to improve the company’s profitability and competitiveness and to secure future operational capacity in a weakened market situation. The company adapts its cost structure and number of...

GUANGZHOU, China, Jan. 04, 2024 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC (“NASDAQ”) dated December 29, 2023, indicating that for the last 30 consecutive business days, the closing bid price for the Company’s American depositary shares (the “ADSs”) was below the minimum bid price of US$1.00 per share requirement set forth in NASDAQ Listing Rule 5450(a)(1). The NASDAQ notification letter has no current effect on the listing or trading of the Company’s securities on NASDAQ. Pursuant to the NASDAQ Listing...

VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today provided unaudited 2023 production volumes for Quebrada Blanca (“QB”) operations, an update on the QB2 project, and unaudited fourth quarter steelmaking coal sales volumes and realized prices. “We are pleased that QB is now operating near design throughput capacity with strong recoveries, positioning Teck for significantly increased copper production in 2024,” said Jonathan Price, President and CEO. “We had strong fourth quarter performance in our steelmaking coal operations, with improvements in plant performance leading to an increase in production, and sales volumes of 6.1 million tonnes near the top end of our guidance.” QB Operations 2023 unaudited contained copper production volumes from...

Combined Company to Benefit from Anticipated Significant Expense Savings, Improved Scale and Capital Efficiency Represents Over $110 Million in Combined Total Assets and $65 Million in Combined Annual Revenue1 Charlotte, NC, Jan. 03, 2024 (GLOBE NEWSWIRE) — FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (NYSE American: FGH) (“FG Group Holdings”) today announced that they have signed a definitive plan of merger to combine the companies in an all-stock transaction. Upon completion of the merger, the combined company will be renamed to Fundamental Global Inc. and the common stock and Series A cumulative preferred stock of the combined company will continue to trade on the Nasdaq under the tickers “FGF” and “FGFPP,” respectively. With combined assets of over $110 million and combined annual...

LEXINGTON, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or “we”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today announced the pricing of an underwritten public offering of 3,500,000 shares of common stock, at a public offering price of $40.00 per share. The gross proceeds to Keros from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $140.0 million. All of the common stock is being offered by Keros. In addition, Keros has granted the underwriters a 30-day option to purchase up to an additional 525,000...